3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8 Purity >98,0% (HPLC) Favipiravir Intermediate COVID-19

Katerangan pondok:

Ngaran Kimia: 3-Hydroxypyrazine-2-Carboxamide

CAS: 55321-99-8

Penampilan: Lampu Konéng nepi Brown Bubuk

Kamurnian: > 98,0% (HPLC)

Panganteur Favipiravir (CAS: 259793-96-9) dina pengobatan inféksi virus Influenza sareng COVID-19

Kualitas luhur, Produksi komérsial

Inquiry: alvin@ruifuchem.com

Kirim surélék ka kami

Rincian produk

Produk patali

Tag produk

Katerangan:

Pasokan Komersial Favipiravir sareng Perantara Patali:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Dietil Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Sipat Kimia:

Ngaran Kimia	3-Hydroxypyrazine-2-Carboxamide
sinonim	T-1105;3-Hydroxy-2-Pyrazinecarboxamide;Favipiravir Desfluoro Impurity;3-Oxo-3,4-dihydropyrazine-2-carboxamide
Nomer CAS	55321-99-8
Nomer CAT	RF-PI295
Status saham	Dina Stok, Skala Produksi Nepi ka Kilogram
Formula Molekul	C5H5N3O2
Beurat Molekul	139.11
merek	Kimia Ruifu

spésifikasi:

Barang	spésifikasi
Penampilan	Bubuk konéng nepi ka coklat
Idéntifikasi	IR, HPLC
Leungitna dina Drying	<1,00%
Najis Tunggal	<0,50%
Logam beurat	≤20ppm
Kasucian	> 98,0% (HPLC)
Standar tés	Standar Perusahaan
Pamakéan	Panganteur Favipiravir (CAS 259793-96-9)

Paket & Panyimpenan:

Bungkusan: Botol, kantong Aluminium foil, 25kg / Drum, atawa nurutkeun sarat customer urang

Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya, Uap

Kaunggulan:

FAQ:

Aplikasi:

3-Hydroxypyrazine-2-Carboxamide (CAS 55321-99-8) mangrupikeun panengah atanapi najis Favipiravir Intermediate (CAS 259793-96-9).Favipiravir mangrupikeun ubar antiviral spéktrum lega énggal.Favipiravir tiasa dianggo pikeun pengobatan antiviral influenza A sareng B. Panaliti nunjukkeun yén salian ti virus influenza, ubar ogé nunjukkeun kagiatan antiviral anu hadé ngalawan rupa-rupa virus RNA, sapertos virus Ebola, virus arena, virus Bunia, sareng rabies. virus.Dina mangsa wabah Panyakit Coronavirus anyar 2019 (COVID-19), Favipiravir tiasa dianggo dina pengobatan pasien COVID-19 anu disarankeun ku WHO.